Cheng Pi Chun, Liptzin Deborah R, Garagozlo Katiana, Barber Andrew T
Division of Pediatric Pulmonology, Allergy, and Sleep Medicine, Riley Hospital for Children, Indianapolis, Indiana, USA.
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Pediatr Pulmonol. 2025 Apr;60(4):e71096. doi: 10.1002/ppul.71096.
The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non-cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer. Recent publications in Pediatric Pulmonology and other journals in 2024 have highlighted new insights into the pathophysiology, disease progression, and emerging diagnostic tools for these rare lung conditions, as well as innovative therapeutic approaches. This review features these important advancements within the context of current diagnostic practices and clinical care for pediatric patients with rare and diffuse lung diseases.
儿科罕见和弥漫性肺部疾病领域不断发展，正在进行的研究加深了我们对儿童间质性和弥漫性肺部疾病（chILD）、非囊性纤维化（CF）支气管扩张以及儿童癌症肺部并发症等疾病的诊断和治疗的理解。2024年发表在《儿科肺病学》和其他期刊上的最新文章突出了对这些罕见肺部疾病的病理生理学、疾病进展、新兴诊断工具以及创新治疗方法的新见解。本综述在当前针对患有罕见和弥漫性肺部疾病的儿科患者的诊断实践和临床护理背景下介绍了这些重要进展。
